Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dahlback, B.
Right arrow Articles by Malm, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dahlback, B.
Right arrow Articles by Malm, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 14, 8127-8135, May, 1990

Characterization of functionally important domains in human vitamin K- dependent protein S using monoclonal antibodies

B Dahlback, B Hildebrand and J Malm
Department of Clinical Chemistry, University of Lund, Malmo General Hospital, Sweden.

Vitamin K-dependent protein S is an anticoagulant plasma protein functioning as a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. To determine which regions in protein S are important for its cofactor activity, we have raised and characterized a large panel of monoclonal antibodies against human protein S. Several of the antibodies were directed against Ca2(+)- dependent epitopes, and they were found to be located either in the domain containing gamma-carboxyglutamic acid (Gla), the thrombin- sensitive region, or in the first epidermal growth factor (EGF)-like domain. The first two types of epitopes were exposed at approximately 1 mM Ca2+, whereas the epitope(s) in the EGF-like domains required less than 1 microM Ca2+, suggesting the presence of one or more high affinity Ca2(+)-binding site(s). The antibodies, as well as their Fab' fragments, against all three types of Ca2(+)-dependent epitopes efficiently inhibited the activated protein C cofactor function of protein S, but through different mechanisms. The antibodies against the Gla domain exerted their effects through inhibition of protein S binding to negatively charged phospholipid. Fab'-fragments of antibodies against the thrombin-sensitive region and the first EGF-like domain were the most potent inhibitors of the activated protein C cofactor function but did not inhibit phospholipid binding of protein S. In conclusion, we have identified the domains in protein S that are important for the activated protein C cofactor activity. The Gla domain is instrumental in the binding of protein S to phospholipid, whereas the thrombin-sensitive region and the first EGF-like domain may be directly involved in protein-protein interactions on the phospholipid surface.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Harmon, R. J. S. Preston, F. N. Ainle, J. A. Johnson, M. S. Cunningham, O. P. Smith, B. White, and J. S. O'Donnell
Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
J. Biol. Chem., November 7, 2008; 283(45): 30531 - 30539.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. S. Preston, E. Ajzner, C. Razzari, S. Karageorgi, S. Dua, B. Dahlback, and D. A. Lane
Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain
J. Biol. Chem., September 29, 2006; 281(39): 28850 - 28857.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. van Zandbergen, A. Bollinger, A. Wenzel, S. Kamhawi, R. Voll, M. Klinger, A. Muller, C. Holscher, M. Herrmann, D. Sacks, et al.
Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum
PNAS, September 12, 2006; 103(37): 13837 - 13842.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Saller, B. O. Villoutreix, A. Amelot, T. Kaabache, B. F. Le Bonniec, M. Aiach, S. Gandrille, and D. Borgel
The {gamma}-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding
Blood, January 1, 2005; 105(1): 122 - 130.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. M. Sere, J. Rosing, and T. M. Hackeng
Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance
Blood, December 1, 2004; 104(12): 3624 - 3630.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Steen, E. A. Norstrom, A.-L. Tholander, P. H. B. Bolton-Maggs, A. Mumford, J. H. McVey, E. G. D. Tuddenham, and B. Dahlback
Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis
Blood, May 1, 2004; 103(9): 3381 - 3387.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Rezende, R. E. Simmonds, and D. A. Lane
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex
Blood, February 15, 2004; 103(4): 1192 - 1201.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Mille-Baker, S. M. Rezende, R. E. Simmonds, P. J. Mason, D. A. Lane, and M. A. Laffan
Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity
Blood, February 15, 2003; 101(4): 1416 - 1418.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Rezende, D. A. Lane, B. Mille-Baker, M. M. Samama, J. Conard, and R. E. Simmonds
Protein S Gla-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency
Blood, September 26, 2002; 100(8): 2812 - 2819.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Webb, A. M. Blom, and B. Dahlback
Vitamin K-Dependent Protein S Localizing Complement Regulator C4b-Binding Protein to the Surface of Apoptotic Cells
J. Immunol., September 1, 2002; 169(5): 2580 - 2586.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. K. Giri, S. Linse, P. G. de Frutos, T. Yamazaki, B. O. Villoutreix, and B. Dahlback
Structural Requirements of Anticoagulant Protein S for Its Binding to the Complement Regulator C4b-binding Protein
J. Biol. Chem., April 19, 2002; 277(17): 15099 - 15106.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. K. Giri, T. Yamazaki, N. Sala, B. Dahlback, and P. G. de Frutos
Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors
Blood, July 15, 2000; 96(2): 523 - 531.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Benzakour and C. Kanthou
The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin
Blood, March 15, 2000; 95(6): 2008 - 2014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. He, L. Shen, B. O. Villoutreix, and B. Dahlback
Amino Acid Residues in Thrombin-sensitive Region and First Epidermal Growth Factor Domain of Vitamin K-dependent Protein S Determining Specificity of the Activated Protein C Cofactor Function
J. Biol. Chem., October 16, 1998; 273(42): 27449 - 27458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Thorelli, R. J. Kaufman, and B. Dahlback
The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V
J. Biol. Chem., June 26, 1998; 273(26): 16140 - 16145.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Leroy-Matheron, M. Gouault-Heilmann, M. Aiach, and S. Gandrille
A Mutation of the Active Protein S Gene Leading to an EGF1-Lacking Protein in a Family With Qualitative (Type II) Deficiency
Blood, June 15, 1998; 91(12): 4608 - 4615.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Xu, B. Dahlback, A.-K. Ohlin, and A. Nilsson
Association of Vitamin K–Dependent Coagulation Proteins and C4b Binding Protein With Triglyceride-Rich Lipoproteins of Human Plasma
Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nakano, Y. Ishimoto, J. Kishino, M. Umeda, K. Inoue, K. Nagata, K. Ohashi, K. Mizuno, and H. Arita
Cell Adhesion to Phosphatidylserine Mediated by a Product of Growth Arrest-specific Gene 6
J. Biol. Chem., November 21, 1997; 272(47): 29411 - 29414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Stenberg, S. Linse, T. Drakenberg, and J. Stenflo
The High Affinity Calcium-binding Sites in the Epidermal Growth Factor Module Region of Vitamin K-dependent Protein S
J. Biol. Chem., September 12, 1997; 272(37): 23255 - 23260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hardig and B. Dahlback
The Amino-terminal Module of the C4b-binding Protein beta -Chain Contains the Protein S-binding Site
J. Biol. Chem., August 23, 1996; 271(34): 20861 - 20867.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Arnljots and B. Dahlback
Antithrombotic Effects of Activated Protein C and Protein S in a Rabbit Model of Microarterial Thrombosis
Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 937 - 941.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement